Steven Kelly

Mr. Steven Kelly is a Chief Executive Officer & Director at Actithera, Inc. and an Independent Director at Artelo Biosciences, Inc. He is on the Board of Directors at Actithera, Inc. and Artelo Biosciences, Inc. Mr. Kelly was previously employed as a Chief Executive Officer by Carisma Therapeutics, Inc., a President, Chief Executive Officer & Director by Carisma Therapeutics, Inc., a President & Chief Executive Officer by CTx Operations, Inc., a President & Chief Executive Officer by Pinteon Therapeutics, Inc., a Principal by Kelly Bioconsulting LLC, a Chief Executive Officer by Theracrine, Inc., a Chief Commercial Officer by BioVex, Inc., and a President & Chief Executive Officer by Innovive Pharmaceuticals, Inc. He received his undergraduate degree from the University of Oregon and an MBA from Cornell University.